Alberti, KG, Zimmet, P, Shaw, J (2005). The metabolic syndrome – a new worldwide definition. Lancet
Alberti, KG, Zimmet, P, Shaw, J (2006). Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine
Alvarez-Jimenez, M, Martinez-Garcia, O, Perez-Iglesias, R, Ramirez, ML, Vazquez-Barquero, JL, Crespo-Facorro, B (2010). Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophrenia Research
American Psychiatric Association (2002). Multiaxial assessment
Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revised (DSM-IV-TR). APA: Arlington, VA.
Arango, C, Bobes, J, Kirkpatrick, B, Garcia-Garcia, M, Rejas, J (2011). Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. European Neuropsychopharmacology
Banham, L, Gilbody, S (2010). Smoking cessation in severe mental illness: what works?
Barnes, TR, Paton, C, Cavanagh, MR, Hancock, E, Taylor, DM (2007). A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin
Basu, R, Brar, JS, Chengappa, KN, John, V, Parepally, H, Gershon, S, Schlicht, P, Kupfer, DJ (2004). The prevalence of the metabolic syndrome in patients with schizoaffective disorder–bipolar subtype. Bipolar Disorders
Bobes, J, Arango, C, Aranda, P, Carmena, R, Garcia-Garcia, M, Rejas, J (2007). Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophrenia Research
Bobes, J, Arango, C, Aranda, P, Carmena, R, Garcia-Garcia, M, Rejas, J (2012). Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study. European Psychiatry
Brown, S, Kim, M, Mitchell, C, Inskip, H (2010). Twenty-five year mortality of a community cohort with schizophrenia. British Journal of Psychiatry
Chang, C-K, Hayes, RD, Perera, G, Broadbent, MTM, Fernandes, AC, Lee, WE, Hotopf, M, Stewart, R (2011). Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS ONE
Craig, CL, Marshall, AL, Sjostrom, M, Bauman, AE, Booth, ML, Ainsworth, BE, Pratt, M, Ekelund, U, Yngve, A, Sallis, JF, Oja, P (2003). International Physical Activity Questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise
Craig, R, Mindell, J (2011). Health Survey for England 2010. The Information Centre: London.
Crawford, MJ, Jayakumar, S, Lemmey, SJ, Zalewska, K, Patel, MX, Cooper, SJ, Shiers, D (2014). Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study. British Journal of Psychiatry
De Hert, M, Correll, CU, Bobes, J, Cetkovich-Bakmas, M, Cohen, D, Asai, I, Detraux, J, Gautam, S, Moller, HJ, Ndetei, DM, Newcomer, JW, Uwakwe, R, Leucht, S (2011). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry
De Hert, M, Dekker, JM, Wood, D, Kahl, KG, Holt, RI, Moller, HJ (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry
Dickerson, F, Stallings, C, Origoni, A, Schroeder, J, Khushalani, S, Yolken, R (2014). Mortality in schizophrenia: clinical and serological predictors. Schizophrenia Bulletin
Fagerstrom, KO (1978). Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors
Fagerstrom, KO, Schneider, NG (1989). Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine
Faulkner, G, Cohn, T, Remington, G (2006). Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophrenia Research
Ford, ES (2005). Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care
Galletly, CA, Foley, DL, Waterreus, A, Watts, GF, Castle, DJ, McGrath, JJ, Mackinnon, A, Morgan, VA (2012). Cardiometabolic risk factors in people with psychotic disorders: the Second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry
Garcia-Portilla, MP, Saiz, PA, Benabarre, A, Sierra, P, Perez, J, Rodriguez, A, Livianos, L, Torres, P, Bobes, J (2008). The prevalence of metabolic syndrome in patients with bipolar disorder. Journal of Affective Disorders
Gaughran, F, Stahl, D, Ismail, K, Atakan, Z, Lally, J, Gardner-Sood, P, Patel, A, David, A, Hopkins, D, Harries, B, Lowe, P, Orr, D, Arbuthnot, M, Murray, R, Greenwood, K, Smith, S (2013). Improving Physical Health and Reducing Substance Use in Psychosis – randomised control trial (IMPaCT RCT): study protocol for a cluster randomised controlled trial. BMC Psychiatry
Grundy, SM, Cleeman, JI, Daniels, SR, Donato, KA, Eckel, RH, Franklin, BA, Gordon, DJ, Krauss, RM, Savage, PJ, Smith, SC Jr, Spertus, JA, Costa, F (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation
Hanley, AJG, Karter, AJ, Williams, K, Festa, A, D'Agostino, RB, Wagenknecht, LE, Haffner, SM (2005). Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: The Insulin Resistance Atherosclerosis Study. Circulation
Hayes, RD, Downs, J, Chang, C-K, Jackson, RG, Shetty, H, Broadbent, M, Hotopf, M, Stewart, R (2014). The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders. Schizophrenia Bulletin. Published online 25 August 2014. doi:10.1093/schbul/sbu120.
Health & Social Care Information Centre (2013). Statistics on Smoking: England, 2013. Health & Social Care Information Centre: Cardiff.
Howes, OD, Gaughran, FP, Amiel, SA, Murray, RM, Pilowsky, LS (2004). The effect of clozapine on factors controlling glucose homeostasis. Journal of Clinical Psychiatry
International Diabetes Federation (2013). IDF Diabetes Atlas. International Diabetes Federation: Brussels, Belgium.
Kay, SR, Opler, LA, Lindenmayer, JP (1989). The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. British Journal of Psychiatry Supplement
Keenan, TE, Yu, A, Cooper, LA, Appel, LJ, Guallar, E, Gennusa, JV III, Dickerson, FB, Crum, RM, Anderson, CA, Campbell, LM, Young, DR, Daumit, GL (2013). Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population. Schizophrenia Research
Khunti, K, Taub, N, Tringham, J, Jarvis, J, Farooqi, A, Skinner, TC, Davies, MJ (2010). Screening for the metabolic syndrome using simple anthropometric measurements in south Asian and white Europeans: a population-based screening study. The Leicester Ethnic Atherosclerosis and Diabetes Risk (LEADER) Study. Primary Care Diabetes
Kilbourne, AM, Morden, NE, Austin, K, Ilgen, M, McCarthy, JF, Dalack, G, Blow, FC (2009). Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. General Hospital Psychiatry
Langan, SM, Seminara, NM, Shin, DB, Troxel, AB, Kimmel, SE, Mehta, NN, Margolis, DJ, Gelfand, JM (2012). Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. Journal of Investigative Dermatology
Langan Martin, J, McLean, G, Park, J, Martin, DJ, Connolly, M, Mercer, SW, Smith, DJ (2014). Impact of socioeconomic deprivation on rate and cause of death in severe mental illness. BMC Psychiatry
Lester, H, Shiers, D, Rafi, I, Cooper, S, Holt, R (2014). Positive Cardiometabolic Health Resource: an Intervention Framework for Patients with Psychosis on Antipsychotic Medication. Royal College of Psychiatrists: London.
Leucht, S, Burkard, T, Henderson, J, Maj, M, Sartorius, N (2007). Physical illness and schizophrenia: a review of the literature. Acta Psychiatrica Scandinavica
Manson, JE, Greenland, P, LaCroix, AZ, Stefanick, ML, Mouton, CP, Oberman, A, Perri, MG, Sheps, DS, Pettinger, MB, Siscovick, DS (2002). Walking compared with vigorous exercise for the prevention of cardiovascular events in women. New England Journal of Medicine
McEvoy, JP, Meyer, JM, Goff, DC, Nasrallah, HA, Davis, SM, Sullivan, L, Meltzer, HY, Hsiao, J, Scott Stroup, T, Lieberman, JA (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research
Meyer, JM, Nasrallah, HA, McEvoy, JP, Goff, DC, Davis, SM, Chakos, M, Patel, JK, Keefe, RS, Stroup, TS, Lieberman, JA (2005). The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophrenia Research
Mitchell, AJ, Vancampfort, D, Sweers, K, van Winkel, R, Yu, W, De Hert, M (2013). Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders – a systematic review and meta-analysis. Schizophrenia Bulletin
Montgomery, SA, Åsberg, M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry
Morgan, VA, McGrath, JJ, Jablensky, A, Badcock, JC, Waterreus, A, Bush, R, Carr, V, Castle, D, Cohen, M, Galletly, C, Harvey, C, Hocking, B, McGorry, P, Neil, AL, Saw, S, Shah, S, Stain, HJ, Mackinnon, A (2014). Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the Second Australian National Survey of Psychosis. Psychological Medicine
NAS (2012). Report of the National Audit of Schizophrenia. Healthcare Quality Improvement Partnership, Royal College of Psychiatrists: London.
Nasrallah, HA, Meyer, JM, Goff, DC, McEvoy, JP, Davis, SM, Stroup, TS, Lieberman, JA (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research
National Institute of Health and Clinical Excellence (2014). National Institute of Health and Clinical Excellence: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. NICE: London.
Nielsen, J, Skadhede, S, Correll, CU (2010). Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naive schizophrenia patients. Neuropsychopharmacology
O'Brien, C, Gardner-Sood, P, Corlett, SK, Ismail, K, Smith, S, Atakan, Z, Greenwood, K, Joseph, C, Gaughran, F (2014). Provision of health promotion programmes to people with serious mental illness: a mapping exercise of four South London boroughs. Journal of Psychiatric and Mental Health Nursing
Osborn, DJ, Levy, G, Nazareth, I, Petersen, I, Islam, A, King, MB (2007). Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's general practice research database. Archives of General Psychiatry
Paffenbarger, RS Jr, Hyde, RT, Wing, AL, Lee, IM, Jung, DL, Kampert, JB (1993). The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. New England Journal of Medicine
Reilly, S, Planner, C, Hann, M, Reeves, D, Nazareth, I, Lester, H (2012). The role of primary care in service provision for people with severe mental illness in the United Kingdom. PLOS ONE
Roe, L, Strong, C, Whiteside, C, Neil, A, Mant, D (1994). Dietary intervention in primary care: validity of the DINE method for diet assessment. Family Practice
Rostami-Hodjegan, A, Amin, AM, Spencer, EP, Lennard, MS, Tucker, GT, Flanagan, RJ (2004). Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients. Journal of Clinical Psychopharmacology
Saha, S, Chant, D, McGrath, J (2007). A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
Archives of General Psychiatry
Saunders, JB, Aasland, OG, Babor, TF, DeLaFuente, JR, Grant, M (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption – II. Addiction
Schizophrenia Commission (2012). The Abandoned Illness: A Report by the Schizophrenia Commission. Rethink Mental Illness: London.
Sobell, L, Sobell, M (1992). Timeline Follow-Back. In Measuring Alcohol Consumption (ed. Litten, R. and Allen, J.), pp. 41–72. Humana Press: New York.
The International Expert Committee (2009). International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care
Tiihonen, J, Lonnqvist, J, Wahlbeck, K, Klaukka, T, Niskanen, L, Tanskanen, A, Haukka, J (2009). 11-Year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet
Vancampfort, D, Knapen, J, Probst, M, Scheewe, T, Remans, S, De Hert, M (2012). A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatrica Scandinavica
Vancampfort, D, Knapen, J, Probst, M, van Winkel, R, Deckx, S, Maurissen, K, Peuskens, J, De Hert, M (2010). Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia. Psychiatry Research
Vancampfort, D, Vansteelandt, K, Correll, CU, Mitchell, AJ, De Herdt, A, Sienaert, P, Probst, M, De Hert, M (2013
a). Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. American Journal of Psychiatry
Vancampfort, D, Wampers, M, Mitchell, AJ, Correll, CU, De Herdt, A, Probst, M, De Hert, M (2013
b). A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry
van Winkel, R, De Hert, M, Van Eyck, D, Hanssens, L, Wampers, M, Scheen, A, Peuskens, J (2008). Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disorders
Walker, E, McGee, RE, Druss, BG (2015). Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. Published online 11 February 2015. doi:10.1001/jamapsychiatry.2014.2502.
Zimmet, P, Alberti, KG, Shaw, J (2001). Global and societal implications of the diabetes epidemic. Nature